Shares of Avalo Therapeutics Inc. (NASDAQ:AVTX) were trading at $21.78, up almost 34%, or $5.52, on positive top-line results from the phase II Lotus trial evaluating the efficacy and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results